Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Active not recruiting

High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma

Advancing The Local Staging Of Pancreatic Ductal Adenocarcinoma Through High-Resolution Ultrasound: A Pilot Study

Outcome
Ongoing
Phase
No phase (not a drug trial)
Status
Active not recruiting
Study type
Interventional
Start
1 February 2019
Expected end
December 2026
Enrollment
30 participants
Sites
1
Primary outcomes
High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC
Sponsor type
Academic / other
Results posted
No
Last update
10 October 2024

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.